PatientView | USA indsigt fra patientgrupper: En plads ved prisbordet

Patientgruppers mål

Procentdelene nedenfor fremhæver, hvordan de 91 patientgrupper interagerer med regulerende myndigheder og varetager patientinteresser. Da respondenter kan være repræsenteret i mere end ét område, er procentdelene muligvis ikke lig med 100%.

interaktioner

Hvordan patientgrupper interagerer med lægemiddelregulatorer

Find ud af, hvad målene betyder

32 omtaler

17 omtaler

15 omtaler

11 omtaler

5 omtaler

1 omtale

handlinger & fortalervirksomhed

Hvordan patientgrupper får adgang til lægemidler

Find ud af, hvad målene betyder

27 omtaler

22 omtaler

3 omtaler

2 omtaler

Engelsk tekst	Terapiområde	Kategori	Patienter nået	Geografisk rækkevidde	Regulatorisk engagement	Respondent
Our community members participate in this at an individual level, and as an organisation, we meet with industry policy holders.	Kræft > Kræft: kvinder	Regulatorisk partnerskab > Arbejde med regulerende myndigheder	10.000	International	Rarely	119028011659
We collaborated on an externally-led Patient-Focused Drug Development meeting with the FDA [Food and Drug Administration] in 2025.	Neurologisk > Multipel sklerose	Regulatorisk partnerskab > Arbejde med regulerende myndigheder	100.000	National	Rarely	119039458452
We engage in education, guidance, and institutional dialogue initiatives to promote informed, equitable decisions that place community well-being at their centre.	Patientadvokatur > Træning	Regulatorisk partnerskab > Arbejde med regulerende myndigheder	100.000	International	Regularly	119063146174
Through written comments, sign-on letters, and participating in roundtable meetings where drugs are being discussed.	Kræft > Kræft: sarkom	Regulatorisk partnerskab > Arbejde med regulerende myndigheder	10.000	International	Sometimes	119064713792
Just recently hosted an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting and attended FDA [Food and Drug Administration] meetings with industry partners.	Sjælden > Sjældne sygdomme: genetisk	Regulatorisk partnerskab > Arbejde med regulerende myndigheder	5.000	International	Regularly	119065526277
... We work closely with the FDA and other drug agencies, like EMA [European Medicines Agency] and PDMA [Pharmaceuticals and Medical Devices Agency], to look at endpoints for drug trials, or how to improve drug trials to benefit sponsors and patients.	Nyre > Nyresygdomme	Regulatorisk partnerskab > Arbejde med regulerende myndigheder	100.000	National	Regularly	119070696943
Participation in activities like PDUFA [Prescription Drug User Fee Act] and MDUFA [Medical Device User Fee and Modernization Act] discussions.	Sjælden > Sjældne sygdomme: de fleste typer	Regulatorisk partnerskab > Arbejde med regulerende myndigheder	100.000	National	Rarely	119078556821
We have a policy committee and weigh in on public policy issues through education and advocacy.	Kronisk > Palliativ	Regulatorisk partnerskab > Arbejde med regulerende myndigheder	100	National	Regularly	119078649119
Discussions about review and approvals of new screening technologies.	Kræft > Kræft: de fleste typer	Regulatorisk partnerskab > Deltag i Health Technology Assessment (HTA) og refusionsgennemgange	100.000	National	Rarely	119045117950
Our organisation actively advocates for the interests of the individuals and communities we serve before regulatory authorities and decision-making bodies on matters relating to medicine access, affordability, and coverage recommendations.	Patientadvokatur > Træning	Regulatorisk partnerskab > Deltag i Health Technology Assessment (HTA) og refusionsgennemgange	100.000	International	Regularly	119063146174
... Our government relations team responds to comment letters and regularly talks with CMS [Centers for Medicare & Medicaid Services] to ensure best outcomes.	Nyre > Nyresygdomme	Regulatorisk partnerskab > Deltag i Health Technology Assessment (HTA) og refusionsgennemgange	100.000	National	Regularly	119070696943
Our organization has participated in responses to ICER [Institute for Clinical and Economic Review].	Respiratorisk > Lungesygdomme	Regulatorisk partnerskab > Deltag i Health Technology Assessment (HTA) og refusionsgennemgange	100.000	International	Rarely	119078556838
We are typically advisors on ICER [Institute for Clinical and Economic Review] reviews.	Reumatisk > Lupus	Regulatorisk partnerskab > Deltag i Health Technology Assessment (HTA) og refusionsgennemgange	100.000	National	Regularly	119082751826
Testifying on behalf of pharma & device companies in front of the FDA [Food and Drug Administration].	Transplantationer > Transplantationer: hjerte og lunge	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	5.000	Local	Regularly	119014633092
Discussions with FDA [Food and Drug Administration].	Generelt helbred > Forskellige fællesskaber	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	10.000	International	Rarely	119026771169
I personally have testified before the FDA [Food and Drug Administration] and CMS [Centers for Medicare & Medicaid Services].	Transplantationer > Transplantationer: hjerte og lunge	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	1.000	Regional	Sometimes	119037216727
We collaborated on an externally-led Patient-Focused Drug Development meeting with the FDA [Food and Drug Administration] in 2025.	Neurologisk > Multipel sklerose	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	100.000	National	Rarely	119039458452
Meeting with people at CMS [Centers for Medicare & Medicaid Services] to weigh in on drug pricing negotiation potential consequences.	Sjælden > Sjældne sygdomme: de fleste typer	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	5.000	National	Sometimes	119046591776
Elevating the patient voice and sharing insights from our patient experience registry at meetings such as ODAC [Oncologic Drugs Advisory Committee] and MDPNP [Medical Device Patient Network Program] listening sessions.	Kræft > Kræft: andet	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	100.000	International	Regularly	119047535935
Communications with FDA [Food and Drug Administration], participating in public comment sessions.	Blod > Anæmi	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	5.000	National	Regularly	119050770645
We work with FDA [Food and Drug Administration], Congress, and the White House on federal policies that affect liver patients.	Lever > Leversygdomme: de fleste typer	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	100.000	International	Regularly	119054948119
Testifying at ODAC [Oncologic Drugs Advisory Committee].	Kræft > Kræft: andet	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	100.000	International	Sometimes	119059387919
Just recently hosted an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting and attended FDA [Food and Drug Administration] meetings with industry partners.	Sjælden > Sjældne sygdomme: genetisk	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	5.000	International	Regularly	119065526277
EL-PFDD [Externally-Led Patient-Focused Drug Development] FDA [Food and Drug Administration] Patient Listening Sessions.	Patientadvokatur > Sundhedsaktivist	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	10.000	National	Regularly	119066130575
We have testified at FDA [Food and Drug Administration] Adcomms [Advisory Committees] and have helped organise Patient-Focused Drug Development meetings.	Neuromuskulær > Neuromuskulære sygdomme: de fleste typer	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	100.000	National	Sometimes	119068005400
Actively participate in Patient Focused Drug Development with FDA [Food and Drug Administration].	Reumatisk > Lupus	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	100.000	National	Regularly	119070039917
We have held multiple externally led patient-focused drug development (EL-PFDD [Externally Led Patient-Focused Drug Development]) meetings with the FDA [Food and Drug Administration]. We invite regulators to all our scientific workshops. We educate patients and facilitate meetings with regulators on an ongoing basis.	Nyre > Nyresygdomme	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	100.000	National	Regularly	119070696943
We provide public comment on new drugs to the FDA [Food and Drug Administration].	Blod > Seglcelleanæmi	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	10.000	Regional	Sometimes	119074242460
Participation in activities like PDUFA [Prescription Drug User Fee Act] and MDUFA [Medical Device User Fee and Modernization Act] discussions.	Sjælden > Sjældne sygdomme: de fleste typer	Regulatorisk partnerskab > Deltag i/faciliter møder med politiske beslutningstagere/regulatorer	100.000	National	Rarely	119078556821
Coalition work.	Sjælden > Sjældne sygdomme: patientrettigheder	Regulatorisk partnerskab > Med andre sundhedsforkæmpere	100.000	National	Sometimes	119050874740
We lead the national coalition EACH [Ensuring Access through Collaborative Health]/PIC [Patient Inclusion Council] coalition, working on government drug affordability reviews.	Autoimmun > Autoimmun: anden	Regulatorisk partnerskab > Med andre sundhedsforkæmpere	100.000	International	Regularly	119071535440
In Arizona and, on occasion, more broadly across the USA, we collaborate with other cancer groups, organisations, and legislators.	Kræft > Kræft: blod	Regulatorisk partnerskab > Med andre sundhedsforkæmpere	Do not know	Regional	Sometimes	119078394447
Lobbying on the state and federal level on rules/laws that impact our patients.	Generelt helbred > Levering af sundhedsydelser	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	100	National	Sometimes	119011450240
Our Cancer Policy Institute advocates for equitable access to medicines to government organizations such as CMS [Centers for Medicare & Medicaid Services].	Kræft > Kræft: andet	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	100.000	International	Regularly	119020437168
We include a discussion of medication pricing in our conversations with the state and federal government employees. We are also pushing for lifetime coverage of physical therapy for people with PD [Parkinson's Disease], as maintaining balance as the disease progresses saves both providers and insurers money in the long run.	Neurodegenerativ > Parkinsons	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	100.000	Regional	Rarely	119020536956
Advocacy with PBM [Pharmacy Benefit Manager], Medicare and state legislatures.	Reumatisk > Lupus	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	5.000	Regional	Sometimes	119037794627
Advocacy with PBM [Pharmacy Benefit Manager], Medicare and state legislatures.	Reumatisk > Lupus	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	5.000	Regional	Sometimes	119037794627
...The organization's flagship event - the annual Indo US Bridging RARE Summit brings together rare disease stakeholders, including scientists, patient advocates, government officials, biopharma executives, and policy experts who share a common goal: transforming the future of care for the 400 million people worldwide living with rare diseases.	Sjælden > Sjældne sygdomme: de fleste typer	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	100	International	Regularly	119038170136
Invitation to the White House in 2024 to discuss cancer research funding with the First Lady's office.	Kræft > Kræft: medicinsk forskning	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	1.000	National	Rarely	119044810653
We work with FDA [Food and Drug Administration], Congress, and the White House on federal policies that affect liver patients.	Lever > Leversygdomme: de fleste typer	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	100.000	International	Regularly	119054948119
We frequently engage on state and federal issues related to patient access to care.	Respiratorisk > Lungesygdomme	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	100.000	National	Rarely	119055217525
We regularly advocate through sign-on letters, policymaker discussions, and policy related programming.	Kræft > Kræft: forskellige fællesskaber	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	5.000	National	Sometimes	119055664199
We both authored and signed on to letters to state and federal (private insurance and CMS [Centers for Medicare & Medicaid Services]) on a variety of issues.	Kardiovaskulær > Hjerte-kar-sygdomme & hjertetilstande	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	Over 100,000	International	Sometimes	119058234393
Campaigning with KidneyCAN for increased federal research funding.	Kræft > Kræft: nyre	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	1.000	Regional	Sometimes	119059282158
The Community Liver Alliance represents patient interests to regulators and policymakers responsible for advising on and determining drug pricing. We engage at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. Our advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies.	Lever > Leversygdomme: de fleste typer	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	100.000	National	Regularly	119059491202
We communicate with federal representatives about the importance of funding.	Kræft > Kræft: hjerne	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	We do not communicate with patients directly	National	Sometimes	119061001133
We bring patient perspectives opposing use of QALYs [Quality-Adjusted Life Years].	Patientadvokatur > Sundhedsaktivist	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	Do not know	National	Regularly	119065430409
Just one example: we continually advocate (both through regulatory comments and now legislation) for adequate reimbursement for new and innovative drugs in the ESRD [End-Stage Renal Disease] space through TDAPA [Transitional Drug Add-on Payment Adjustment] and a sustainable post-TDAPA payment pathway.	Nyre > Nyresygdomme	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	Over 100,000	National	Regularly	119068073151
We work with state, federal policymakers and health insurers.	Generelt helbred > Fedme	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	Over 100,000	National	Sometimes	119068989651
As a transgender-led healthcare organization, ETSI [Ending Transmission of Sexual Infections] also brings the perspective of historically marginalized communities into healthcare discussions. The clinic advocates for policies that protect medication affordability, expand HIV prevention services, and strengthen programs that reduce the cost of prescription drugs for safety-net providers. Through patient care, community engagement, and participation in public health programs, ETSI Health Clinic ensures that the voices and needs of vulnerable patients are represented in conversations about medication access and healthcare equity.	HIV > HIV og seksuel sundhed	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	100	Regional	Regularly	119073874628
Supported efforts to have an ICD-10 (International Classification of Diseases, 10th Revision) code for VEXAS syndrome.	Sjælden > Autoinflammatiske sygdomme	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	1.000	International	Sometimes	119074154009
We provide public comment on new drugs to the FDA. We regularly organize delegations to Capitol Hill to advocate for Medicaid and Medicare support for sickle cell treatment. We advocate with New Jersey legislators for support for sickle cell treatment and services.	Blod > Seglcelleanæmi	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	10.000	Regional	Sometimes	119074242460
Testifying at PDAB meetings [submitting comments to a Patient Drug Affordability Board during a public meeting, hearing, or review process] writing letters to decision-makers at state and federal level [USA].	Sjælden > Cystisk fibrose	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	10.000	National	Sometimes	119078388026
In Arizona and occasionally, the U.S., we collaborate with other cancer groups, organizations, and legislators who support legislation that will help cancer research, the medical/oncology groups, and cancer patients and families.	Kræft > Kræft: blod	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	Do not know	Regional	Sometimes	119078394447
We have a policy committee and weigh in on public policy issues through education and advocacy.	Kronisk > Palliativ	Indflydelse på politik og lovgivning > Påvirk sundhedspolitik og lovgivning	100	National	Regularly	119078649119
We include a discussion of medication pricing in our discussions with state and federal government employees.	Neurodegenerativ > Parkinsons	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	100.000	Regional	Rarely	119020536956
We submitted comments to CMS [Centers for Medicare & Medicaid Services] regarding the price negotiation of mental health and neurological conditions.	Mental sundhed > Mental sundhed: stigma	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	We do not communicate with patients directly	National	Sometimes	119024698241
IndoUSrare participates in RDLA's [Rare Disease Legislative Advocates] Rare Disease Week on Capitol Hill and advocates to legislators on behalf of our patient alliance members and the rare disease community.	Sjælden > Sjældne sygdomme: de fleste typer	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	100	International	Regularly	119038170136
Testify before prescription drug affordability boards.	Blødning > Blødningsforstyrrelser: de fleste typer	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	1.000	Local	Regularly	119044404340
Communications with FDA [Food and Drug Administration], participating in public comment sessions.	Blod > Anæmi	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	5.000	National	Regularly	119050770645
We regularly advocate through sign-on letters, policymaker discussions, and policy related programming.	Kræft > Kræft: forskellige fællesskaber	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	5.000	National	Sometimes	119055664199
We both authored and signed on to letters to state and federal (private insurance and CMS [Centers for Medicare & Medicaid Services]) on a variety of issues.	Kardiovaskulær > Hjerte-kar-sygdomme & hjertetilstande	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	Over 100,000	International	Sometimes	119058234393
... Testifying at IRA [Inflation Reduction Act] listening sessions to elevate the patient experience.	Kræft > Kræft: andet	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	100.000	International	Sometimes	119059387919
The Community Liver Alliance engages at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. The Community Liver Alliance's advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases.	Lever > Leversygdomme: de fleste typer	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	100.000	National	Regularly	119059491202
Through written comments, sign-on letters, and participating in roundtable meetings where drugs are being discussed.	Kræft > Kræft: sarkom	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	10.000	International	Sometimes	119064713792
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Blødning > Blødningsforstyrrelser: de fleste typer	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	5.000	Regional	Regularly	119069774462
... Our government relations team responds to comment letters and regularly talks with CMS [Centers for Medicare & Medicaid Services] to ensure best outcomes.	Nyre > Nyresygdomme	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	100.000	National	Regularly	119070696943
We provided comments to federal and state regulators around drug pricing in the 340B program [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics] when asking for community input to proposed policy changes.	Patientuddannelse > Patientoplysninger	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	5.000	National	Sometimes	119073380443
We are not a lobbying organization, we are a 501 c-3 non-profit public charity. We sign on to letters with partner societies who are lobbying for better access to care. We host roundtables and advocacy awareness days with legislators where we raise awareness of current problems and offer solutions. One recent event was with the Governor of Virginia. We are planning a Spine Health Fair at the US Capitol in September.	Generelt helbred > Livsstil	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	100.000	National	Sometimes	119074217249
We provide public comment on new drugs to the FDA [Food and Drug Administration].	Blod > Seglcelleanæmi	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	10.000	Regional	Sometimes	119074242460
Work with NYSTAG [New York State Technical Advisory Group-generally refers to ad-hoc or specialised panels of industry experts, academics, and stakeholders assembled by NY state agencies to advise on specific policies, healthcare, or emerging technologies.].	Generelt helbred > Levering af sundhedsydelser	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	5.000	Regional	Sometimes	119078326039
Testifying at PDAB meetings [submitting comments to a Patient Drug Affordability Board during a public meeting, hearing, or review process] writing letters to decision-makers at state and federal level [USA].	Sjælden > Cystisk fibrose	Indflydelse på politik og lovgivning > Deltag i offentlige høringer og konsultationer	10.000	National	Sometimes	119078388026
IndoUSrare participates in RDLA's [Rare Disease Legislative Advocates] Rare Disease Week on Capitol Hill and advocates to legislators on behalf of our patient alliance members and the rare disease community.	Sjælden > Sjældne sygdomme: de fleste typer	Indflydelse på politik og lovgivning > Mobiliser parlamentarikere og politiske ledere	100	International	Regularly	119038170136
Invitation to the White House in 2024 to discuss cancer research funding with the First Lady's office.	Kræft > Kræft: medicinsk forskning	Indflydelse på politik og lovgivning > Mobiliser parlamentarikere og politiske ledere	1.000	National	Rarely	119044810653
We communicate with federal representatives about the importance of funding.	Kræft > Kræft: hjerne	Indflydelse på politik og lovgivning > Mobiliser parlamentarikere og politiske ledere	We do not communicate with patients directly	National	Sometimes	119061001133
We provide public comment on new drugs to the FDA. We regularly organize delegations to Capitol Hill to advocate for Medicaid and Medicare support for sickle cell treatment. We advocate with New Jersey legislators for support for sickle cell treatment and services.	Blod > Seglcelleanæmi	Indflydelse på politik og lovgivning > Mobiliser parlamentarikere og politiske ledere	10.000	Regional	Sometimes	119074242460
... We are active in Lupus Caucus [Congressional Lupus Caucus, a bipartisan group of lawmakers focused on raising awareness about lupus and securing federal funding for research and education]	Reumatisk > Lupus	Indflydelse på politik og lovgivning > Mobiliser parlamentarikere og politiske ledere	100.000	National	Regularly	119082751826
Government Relations/Advocacy team signs letters in support of lower drug prices.	Kræft > Kræft: prostata	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	100.000	National	Sometimes	119011723588
We include a discussion of medication pricing in our discussions with state and federal government employees.	Neurodegenerativ > Parkinsons	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	100.000	Regional	Rarely	119020536956
Testify before prescription drug affordability boards.	Blødning > Blødningsforstyrrelser: de fleste typer	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	1.000	Local	Regularly	119044404340
Drug assistance programs and co-pay assistance foundation.	Kræft > Kræft: de fleste typer	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	5.000	International	Sometimes	119045428228
We frequently engage on state and federal issues related to patient access to care, occasionally weighing in on issues adjacent to drug pricing, though it is not our primary focus.	Respiratorisk > Lungesygdomme	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	100.000	National	Rarely	119055217525
The Community Liver Alliance represents patient interests to regulators and policymakers responsible for advising on and determining drug pricing. We engage at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. Our advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies	Lever > Leversygdomme: de fleste typer	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	100.000	National	Regularly	119059491202
Promoting 340B reforms [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics].	Patientadvokatur > Sundhedsaktivist	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	10.000	Regional	Regularly	119059636045
Have written support letters from the "patient voice" as part of our advocacy efforts related to drug pricing.	Kræft > Kræft: hjerne	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	1.000	National	Rarely	119061176158
Our organisation actively advocates for the interests of the individuals and communities we serve before regulatory authorities and decision-making bodies on matters relating to medicine access, affordability, and coverage recommendations.	Patientadvokatur > Træning	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	100.000	International	Regularly	119063146174
We bring patient perspectives opposing use of QUALYs [quality-adjusted life years] and opposing importing drug prices from other countries [oustide of the USA], especially those that use QALYs.	Patientadvokatur > Sundhedsaktivist	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	Do not know	National	Regularly	119065430409
Just one example: we continually advocate (both through regulatory comments and now legislation) for adequate reimbursement for new and innovative drugs in the ESRD [End-Stage Renal Disease] space through TDAPA [Transitional Drug Add-on Payment Adjustment] and a sustainable post-TDAPA payment pathway.	Nyre > Nyresygdomme	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	Over 100,000	National	Regularly	119068073151
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Blødning > Blødningsforstyrrelser: de fleste typer	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	5.000	Regional	Regularly	119069774462
ETSI [Ending Transmission of Sexual Infections] Health Clinic represents the interests of patients—particularly those impacted by HIV, LGBTQ+ individuals, and underserved communities—by advocating for affordable access to life-saving medications.	HIV > HIV og seksuel sundhed	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	100	Regional	Regularly	119073874628
Pharma pricing.	Generelt helbred > Fedme	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	100.000	National	Regularly	119076659022
With our new Public Policy department, this may come up as an opportunity to advocate for drug pricing.	Neurodegenerativ > Parkinsons	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	100.000	National	Sometimes	119078318937
Cost for SCD [Sickle Cell Disease] treatments as they came to market during the last 7 years.	Blod > Seglcelleanæmi	Prisfastsættelse og overkommelighed > Fortaler for retfærdig medicinprissætning	5.000	National	Sometimes	119079213376
We have participated in the IRA [Inflation Reduction Act] price negotiation round tables.	Respiratorisk > Astma og allergi	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	100.000	National	Regularly	119011501209
We have participated in the IRA [Inflation Reduction Act of 2022] price negotiation round tables [The IRA provides Medicare (the US federal health insurance program for people age 65 and older) powers to negotiate lower prescription costs].	Respiratorisk > Astma og allergi	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	100.000	National	Regularly	119011501209
We submitted comments to CMS [Centers for Medicare & Medicaid Services] regarding the price negotiation of mental health and neurological conditions.	Mental sundhed > Mental sundhed: stigma	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	We do not communicate with patients directly	National	Sometimes	119024698241
... meetings with state office of CMS [Centers for Medicare & Medicaid Services].	Blødning > Blødningsforstyrrelser: de fleste typer	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	1.000	Local	Regularly	119044404340
Meeting with people at CMS [Centers for Medicare & Medicaid Services] to weigh in on drug pricing negotiation potential consequences.	Sjælden > Sjældne sygdomme: de fleste typer	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	5.000	National	Sometimes	119046591776
We educate advocates on outreach to Patient Drug Affordability Boards [Patient Drug Affordability Boards are state government boards that review prescription drug prices and, in some US states, can take actions to help make drugs more affordable.]	Kræft > Kræft: forskellige fællesskaber	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	100.000	National	Sometimes	119054172981
The Community Liver Alliance's advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases.	Lever > Leversygdomme: de fleste typer	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	100.000	National	Regularly	119059491202
PDABs [Prescription Drug Affordability Boards]; IRA [Inflation Reduction Act]; Medicaid P&T [Pharmacy and Therapeutics] committees.	Patientadvokatur > Sundhedsaktivist	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	We do not communicate with patients directly	National	Regularly	119064160791
We participated in the Medicare price negotiation roundtables and town hall last year.	Respiratorisk > Astma og allergi	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	100.000	National	Regularly	119069847466
Actively participate in patient-focused drug development with the FDA [Food and Drug Administration] and CMS [Centers for Medicare & Medicaid Services]/HHS [U.S. Department of Health and Human Services] Prescription Access discussions.	Reumatisk > Lupus	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	100.000	National	Regularly	119070039917
We lead the national coalition EACH [Ensuring Access through Collaborative Health]/PIC [Patient Inclusion Council] coalition, working on government drug affordability reviews.	Autoimmun > Autoimmun: anden	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	100.000	International	Regularly	119071535440
We provided comments to federal and state regulators around drug pricing in the 340B program [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics] when asking for community input to proposed policy changes.	Patientuddannelse > Patientoplysninger	Prisfastsættelse og overkommelighed > Deltag i forhandlinger med prisrevisionsnævnet	5.000	National	Sometimes	119073380443
We communicate to them that many HD [Huntington's disease] families are low income as often the one making the money is the one with HD. So cost of meds can impact whether they can afford the meds.	Neurodegenerativ > Huntingtons sygdom	Prisfastsættelse og overkommelighed > Adresser omkostningsbarrierer for lavindkomst- og sårbare personer	100.000	National	Sometimes	119017688949
Health insurance companies and health insurance reps organize activities for low income communities.	Ældre mennesker > Ældre mennesker	Prisfastsættelse og overkommelighed > Adresser omkostningsbarrierer for lavindkomst- og sårbare personer	Over 100,000	International	Sometimes	119035935608
ETSI [Ending Transmission of Sexual Infections] Health Clinic represents the interests of patients—particularly those impacted by HIV, LGBTQ+ individuals, and underserved communities—by advocating for affordable access to life-saving medications and healthcare services. Through its participation in programs such as the 340B Drug Pricing Program [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics], ETSI works to ensure that low-income and uninsured patients have access to reduced-cost prescription medications, including HIV treatment and prevention medications like PrEP.	HIV > HIV og seksuel sundhed	Prisfastsættelse og overkommelighed > Adresser omkostningsbarrierer for lavindkomst- og sårbare personer	100	Regional	Regularly	119073874628
We regularly provide comments to state P&T [Pharmacy and Therapeutics] committees regarding their formulary inclusions and exclusions.	Respiratorisk > Astma og allergi	Prisfastsættelse og overkommelighed > Fortalelse af optagelse af produktet på refusionslister/nationale formularer	100.000	National	Regularly	119011501209
PDABs [Prescription Drug Affordability Boards]; IRA [Inflation Reduction Act]; Medicaid P&T [Pharmacy and Therapeutics] committees.	Patientadvokatur > Sundhedsaktivist	Prisfastsættelse og overkommelighed > Fortalelse af optagelse af produktet på refusionslister/nationale formularer	We do not communicate with patients directly	National	Regularly	119064160791
Invitation to the White House in 2024 to discuss cancer research funding with First Lady's office. Lastly, I've co-written op-eds and on the local level recorded a video (ACS) targeting NYS lawmakers and the advocacy for increased equity and access to biomarker testing for patients.	Kræft > Kræft: medicinsk forskning	Prisfastsættelse og overkommelighed > Deltage i oplysningskampagner	1.000	National	Rarely	119044810653
Advocacy in access to care issues.	Kræft > Kræft: de fleste typer	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	10.000	Regional	Sometimes	119011457943
Our Cancer Policy Institute advocates for equitable access to medicines to government organizations such as CMS [Centers for Medicare & Medicaid Services].	Kræft > Kræft: andet	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	100.000	International	Regularly	119020437168
We include a discussion of medication pricing in our conversations with the state and federal government employees. We are also pushing for lifetime coverage of physical therapy for people with PD [Parkinson's Disease], as maintaining balance as the disease progresses saves both providers and insurers money in the long run.	Neurodegenerativ > Parkinsons	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	100.000	Regional	Rarely	119020536956
... We sent letters to States to request that they change their step requirements for access to mental health treatments.	Mental sundhed > Mental sundhed: stigma	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	We do not communicate with patients directly	National	Sometimes	119024698241
Invitation to the White House in 2024 to discuss cancer research funding with First Lady's office. Lastly, I've co-written op-eds and on the local level recorded a video (ACS) targeting NYS lawmakers and the advocacy for increased equity and access to biomarker testing for patients.	Kræft > Kræft: medicinsk forskning	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	1.000	National	Rarely	119044810653
Drug assistance programs and co-pay assistance foundation.	Kræft > Kræft: de fleste typer	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	5.000	International	Sometimes	119045428228
We frequently engage on state and federal issues related to patient access to care.	Respiratorisk > Lungesygdomme	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	100.000	National	Rarely	119055217525
The Community Liver Alliance elevates patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies.	Lever > Leversygdomme: de fleste typer	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	100.000	National	Regularly	119059491202
We might provide patient stories and testimonials when needed to ensure importance of continued access to a particular drug.	Neurologisk > Migræne/andre hovedpinelidelser	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	100.000	National	Rarely	119060019780
Our organisation actively advocates for the interests of the individuals and communities we serve before regulatory authorities and decision-making bodies on matters relating to medicine access, affordability, and coverage recommendations.	Patientadvokatur > Træning	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	100.000	International	Regularly	119063146174
State level Medicaid.	Kræft > Kræft: de fleste typer	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	1.000	National	Rarely	119068136322
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Blødning > Blødningsforstyrrelser: de fleste typer	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	5.000	Regional	Regularly	119069774462
We are currently addressing access to biologic medications.	Sjælden > Sjældne sygdomme: immunsystem	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	10.000	National	Sometimes	119069849386
Actively participate in patient-focused drug development with the FDA [Food and Drug Administration] and CMS [Centers for Medicare & Medicaid Services]/HHS [U.S. Department of Health and Human Services] Prescription Access discussions.	Reumatisk > Lupus	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	100.000	National	Regularly	119070039917
We are not a lobbying organization, we are a 501 c-3 non-profit public charity. We sign on to letters with partner societies who are lobbying for better access to care. Support with formal cost-approval (reimbursement authorisation) applications and with newly introduced restrictions on treatment options.	Generelt helbred > Livsstil	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	100.000	National	Sometimes	119074217249
Pharma pricing, coverage, indications.	Generelt helbred > Fedme	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	100.000	National	Regularly	119076659022
We have on only a few occasions advocated for better access to newer drugs.	Mental sundhed > Mental sundhed: stigma	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	Over 100,000	International	Rarely	119078209025
Cost for SCD [Sickle Cell Disease] treatments as they came to market during the last 7 years.	Blod > Seglcelleanæmi	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	5.000	National	Sometimes	119079213376
... convene MAPRx [Medicare Access for Patients Rx] for Medicare Part D, etc.[MAPRx is guided by the idea that every Medicare Part D beneficiary should have timely, affordable access to the medications they need to live a healthy life.]	Reumatisk > Lupus	Forbedring af adgangsveje > Fremme retfærdig adgang til medicin/sundhedspleje	100.000	National	Regularly	119082751826
... We sent letters to States to request that they change their step requirements for access to mental health treatments.	Mental sundhed > Mental sundhed: stigma	Forbedring af adgangsveje > Håndter uligheder i adgang og administration	We do not communicate with patients directly	National	Sometimes	119024698241
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Blødning > Blødningsforstyrrelser: de fleste typer	Forbedring af adgangsveje > Håndter uligheder i adgang og administration	5.000	Regional	Regularly	119069774462
IndoUSrare participates in RDLA's [Rare Disease Legislative Advocates] Rare Disease Week on Capitol Hill and advocates to legislators on behalf of our patient alliance members and the rare disease community.	Sjælden > Sjældne sygdomme: de fleste typer	Forbedring af adgangsveje > Forbedring af adgangen til sjældne/ultrasjældne behandlinger	100	International	Regularly	119038170136
Elevating the patient voice and sharing insights from our patient experience registry at meetings such as ODAC [Oncologic Drugs Advisory Committee] and MDPNP [Medical Device Patient Network Program] listening sessions.	Kræft > Kræft: andet	Evidensbaseret patientinput > Brug patientindsigt til at informere beslutninger	100.000	International	Regularly	119047535935
Elevating the patient voice and sharing insights from our patient experience registry at meetings such as ODAC [Oncologic Drugs Advisory Committee] and MDPNP [Medical Device Patient Network Program] listening sessions.	Kræft > Kræft: andet	Evidensbaseret patientinput > Brug patientindsigt til at informere beslutninger	100.000	International	Regularly	119047535935
Held an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting.	Neurodegenerativ > Demens	Evidensbaseret patientinput > Brug patientindsigt til at informere beslutninger	Do not know	National	Sometimes	119052219350
Serve on the Alliance for Breast Cancer Policy [The Alliance for Breast Cancer Policy is a coalition of over 25 national patient advocacy organizations founded by Susan G. Komen. The network unites advocates, community members, and industry partners to drive federal policy changes that improve access to care, eliminate out-of-pocket costs, and improve outcomes]. We were just part of a manuscript written for the launch of the global Breast Cancer Care Quality Index: https://www.mdpi.com/1660-4601/23/2/207	Kræft > Kræft: bryst	Evidensbaseret patientinput > Brug patientindsigt til at informere beslutninger	100.000	International	Sometimes	119052475951
We bring patient perspectives opposing use of QALYs [Quality-Adjusted Life Years].	Patientadvokatur > Sundhedsaktivist	Evidensbaseret patientinput > Brug patientindsigt til at informere beslutninger	Do not know	National	Regularly	119065430409
Actively participate in Patient Focused Drug Development with FDA [Food and Drug Administration].	Reumatisk > Lupus	Evidensbaseret patientinput > Brug patientindsigt til at informere beslutninger	100.000	National	Regularly	119070039917
We have held multiple externally led patient-focused drug development (EL-PFDD [Externally Led Patient-Focused Drug Development]) meetings with the FDA [Food and Drug Administration].	Nyre > Nyresygdomme	Evidensbaseret patientinput > Brug patientindsigt til at informere beslutninger	100.000	National	Regularly	119070696943
As a transgender-led healthcare organization, ETSI [Ending Transmission of Sexual Infections] also brings the perspective of historically marginalized communities into healthcare discussions. The clinic advocates for policies that protect medication affordability, expand HIV prevention services, and strengthen programs that reduce the cost of prescription drugs for safety-net providers. Through patient care, community engagement, and participation in public health programs, ETSI Health Clinic ensures that the voices and needs of vulnerable patients are represented in conversations about medication access and healthcare equity.	HIV > HIV og seksuel sundhed	Evidensbaseret patientinput > Brug patientindsigt til at informere beslutninger	100	Regional	Regularly	119073874628
We provide data and real-world knowledge.	Lever > Leversygdomme: de fleste typer	Evidensbaseret patientinput > Lever Real-World Evidence (RWE) til regulatoriske myndigheder	100.000	National	Sometimes	119045306046
The Community Liver Alliance represents patient interests to regulators and policymakers responsible for advising on and determining drug pricing. We engage at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. Our advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies	Lever > Leversygdomme: de fleste typer	Evidensbaseret patientinput > Lever Real-World Evidence (RWE) til regulatoriske myndigheder	100.000	National	Regularly	119059491202
ETSI [Ending Transmission of Sexual Infections] Health Clinic collaborates with pharmacy partners and public health systems to highlight the real-world impact that medication costs have on patients living with HIV and those at risk. By documenting patient barriers to medication access, the clinic helps inform healthcare partners and policymakers about the financial and systemic challenges patients face.	HIV > HIV og seksuel sundhed	Evidensbaseret patientinput > Lever Real-World Evidence (RWE) til regulatoriske myndigheder	100	Regional	Regularly	119073874628
We communicate to them that many HD [Huntington's Disease] families are low income, as often the one making the money is the one with HD.	Neurodegenerativ > Huntingtons sygdom	Evidensbaseret patientinput > Udnyt patienthistorier og fortællinger om levede erfaringer	100.000	National	Sometimes	119017688949
The Community Liver Alliance engages at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies.	Lever > Leversygdomme: de fleste typer	Evidensbaseret patientinput > Udnyt patienthistorier og fortællinger om levede erfaringer	100.000	National	Regularly	119059491202
We might provide patient stories and testimonials when needed to ensure importance of continued access to a particular drug.	Neurologisk > Migræne/andre hovedpinelidelser	Evidensbaseret patientinput > Udnyt patienthistorier og fortællinger om levede erfaringer	100.000	National	Rarely	119060019780
Have written support letters from the "patient voice" as part of our advocacy efforts related to drug pricing.	Kræft > Kræft: hjerne	Evidensbaseret patientinput > Udnyt patienthistorier og fortællinger om levede erfaringer	1.000	National	Rarely	119061176158
Held an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting.	Neurodegenerativ > Demens	Evidensbaseret patientinput > Gennemfør undersøgelser/forskning for at generere data	Do not know	National	Sometimes	119052219350
Serve on the Alliance for Breast Cancer Policy [The Alliance for Breast Cancer Policy is a coalition of over 25 national patient advocacy organizations founded by Susan G. Komen. The network unites advocates, community members, and industry partners to drive federal policy changes that improve access to care, eliminate out-of-pocket costs, and improve outcomes]. We were just part of a manuscript written for the launch of the global Breast Cancer Care Quality Index: https://www.mdpi.com/1660-4601/23/2/207	Kræft > Kræft: bryst	Evidensbaseret patientinput > Gennemfør undersøgelser/forskning for at generere data	100.000	International	Sometimes	119052475951
As a transgender-led healthcare organization, ETSI [Ending Transmission of Sexual Infections] also brings the perspective of historically marginalized communities into healthcare discussions. The clinic advocates for policies that protect medication affordability, expand HIV prevention services, and strengthen programs that reduce the cost of prescription drugs for safety-net providers. Through patient care, community engagement, and participation in public health programs, ETSI Health Clinic ensures that the voices and needs of vulnerable patients are represented in conversations about medication access and healthcare equity.	HIV > HIV og seksuel sundhed	Evidensbaseret patientinput > Omsæt evidens og indsigter til politisk input	100	Regional	Regularly	119073874628
... We work closely with the FDA and other drug agencies, like EMA [European Medicines Agency] and PDMA [Pharmaceuticals and Medical Devices Agency], to look at endpoints for drug trials, or how to improve drug trials to benefit sponsors and patients.	Nyre > Nyresygdomme	Diagnose og medicinlevering > Samarbejd om design af kliniske forsøg	100.000	National	Regularly	119070696943
Supporting legislation for multiple cancer early detection, including TV appearances and social media.	Kræft > Kræft: plejere, familie, venner	Diagnose og medicinlevering > Støtte til screening og tidlig opdagelse	1.000	Regional	Regularly	119036085844
Discussions about review and approvals of new screening technologies.	Kræft > Kræft: de fleste typer	Diagnose og medicinlevering > Støtte til screening og tidlig opdagelse	100.000	National	Rarely	119045117950
USPTF [U.S. Preventive Services Task Force] input.	Kræft > Kræft: mænd	Diagnose og medicinlevering > Støtte til screening og tidlig opdagelse	100.000	National	Sometimes	119050776275
Sit on several panels.	Kræft > Kræft: bryst	Institutionel styring > Sikre repræsentation i statslige rådgivende organer	100	Regional	Regularly	119037236943
... The organization's flagship event - the annual Indo US Bridging RARE Summit brings together rare disease stakeholders, including scientists, patient advocates, government officials, biopharma executives, and policy experts who share a common goal: transforming the future of care for the 400 million people worldwide living with rare diseases.	Sjælden > Sjældne sygdomme: de fleste typer	Institutionel styring > Effektivt arbejde i netværk med flere interessenter	100	International	Regularly	119038170136
Serve on the Alliance for Breast Cancer Policy [The Alliance for Breast Cancer Policy is a coalition of over 25 national patient advocacy organizations founded by Susan G. Komen. The network unites advocates, community members, and industry partners to drive federal policy changes that improve access to care, eliminate out-of-pocket costs, and improve outcomes]. We were just part of a manuscript written for the launch of the global Breast Cancer Care Quality Index: https://www.mdpi.com/1660-4601/23/2/207	Kræft > Kræft: bryst	Institutionel styring > Effektivt arbejde i netværk med flere interessenter	100.000	International	Sometimes	119052475951
We are not a lobbying organization, we are a 501 c-3 non-profit public charity. We sign on to letters with partner societies who are lobbying for better access to care. We host roundtables and advocacy awareness days with legislators where we raise awareness of current problems and offer solutions. One recent event was with the Governor of Virginia. We are planning a Spine Health Fair at the US Capitol in September.	Generelt helbred > Livsstil	Institutionel styring > Effektivt arbejde i netværk med flere interessenter	100.000	National	Sometimes	119074217249
We are typically advisors on ICER [Institute for Clinical and Economic Review] reviews, active in Lupus Caucus, convene MAPRx [Medicare Access for Patients Rx] for Medicare Part D, etc.[MAPRx is guided by the idea that every Medicare Part D beneficiary should have timely, affordable access to the medications they need to live a healthy life.]	Reumatisk > Lupus	Institutionel styring > Effektivt arbejde i netværk med flere interessenter	100.000	National	Regularly	119082751826

USA

Undersøgelsesindsigt

Patientgruppers stemmer

Patientgruppers mål

Hvordan patientgrupper interagerer med lægemiddelregulatorer

Hvordan patientgrupper får adgang til lægemidler

Få adgang til de fulde resultater

Download eksempelrapporter